Cargando…
Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit
Introduction: Many severe COVID-19 patients require respiratory support and monitoring. An intermediate respiratory care unit (IMCU) may be a valuable element for optimizing patient care and limited health-care resources management. We aim to assess the clinical outcomes of severe COVID-19 patients...
Autores principales: | Suarez-Cuartin, Guillermo, Gasa, Merce, Bermudo, Guadalupe, Ruiz, Yolanda, Hernandez-Argudo, Marta, Marin, Alfredo, Trias-Sabria, Pere, Cordoba, Ana, Cuevas, Ester, Sarasate, Mikel, Ariza, Albert, Sabater, Joan, Romero, Nuria, Subirana, Cristina, Molina-Molina, Maria, Santos, Salud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280318/ https://www.ncbi.nlm.nih.gov/pubmed/34277674 http://dx.doi.org/10.3389/fmed.2021.711027 |
Ejemplares similares
-
Outcomes of COVID-19 Patients Admitted to the Intermediate Respiratory Care Unit: Non-Invasive Respiratory Therapy in a Sequential Protocol
por: Gasa, Mercè, et al.
Publicado: (2022) -
Radio-Histological Correlation of Lung Features in Severe COVID-19 Through CT-Scan and Lung Ultrasound Evaluation
por: Trias-Sabrià, Pere, et al.
Publicado: (2022) -
Effects of Early Physical Therapy and Follow-Up in Acute Severe Coronavirus Disease 2019 Pneumonia: A Retrospective Observational Study
por: Bordas-Martínez, Jaume, et al.
Publicado: (2022) -
Idiopathic pulmonary fibrosis cluster analysis highlights diagnostic delay and cardiovascular comorbidity association with outcome
por: Bordas-Martínez, Jaume, et al.
Publicado: (2021) -
Experience With Nintedanib in Severe Pulmonary Fibrosis Associated With Systemic Sclerosis: A Case Series
por: Bordas-Martinez, Jaume, et al.
Publicado: (2021)